Product
NMS-01940153E
1 clinical trial
1 indication
Indication
Hepatocellular Carcinoma (HCC)Clinical trial
Phase I/II Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic TherapyStatus: Active (not recruiting), Estimated PCD: 2024-01-31